191 related articles for article (PubMed ID: 21631428)
1. HIV-1 reactivation induced by apicidin involves histone modification in latently infected cells.
Lin S; Zhang Y; Ying H; Zhu H
Curr HIV Res; 2011 Jun; 9(4):202-8. PubMed ID: 21631428
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitor MC1293 induces latent HIV-1 reactivation by histone modification in vitro latency cell lines.
Qu X; Ying H; Wang X; Kong C; Zhou X; Wang P; Zhu H
Curr HIV Res; 2013 Jan; 11(1):24-9. PubMed ID: 23092175
[TBL] [Abstract][Full Text] [Related]
3. The Suv39H1 methyltransferase inhibitor chaetocin causes induction of integrated HIV-1 without producing a T cell response.
Bernhard W; Barreto K; Saunders A; Dahabieh MS; Johnson P; Sadowski I
FEBS Lett; 2011 Nov; 585(22):3549-54. PubMed ID: 22020221
[TBL] [Abstract][Full Text] [Related]
4. Selective histonedeacetylase inhibitor M344 intervenes in HIV-1 latency through increasing histone acetylation and activation of NF-kappaB.
Ying H; Zhang Y; Zhou X; Qu X; Wang P; Liu S; Lu D; Zhu H
PLoS One; 2012; 7(11):e48832. PubMed ID: 23166597
[TBL] [Abstract][Full Text] [Related]
5. Histonedeacetylase inhibitor Oxamflatin increase HIV-1 transcription by inducing histone modification in latently infected cells.
Yin H; Zhang Y; Zhou X; Zhu H
Mol Biol Rep; 2011 Nov; 38(8):5071-8. PubMed ID: 21181272
[TBL] [Abstract][Full Text] [Related]
6. Chromatin-associated regulation of HIV-1 transcription: implications for the development of therapeutic strategies.
Quivy V; De Walque S; Van Lint C
Subcell Biochem; 2007; 41():371-96. PubMed ID: 17484137
[TBL] [Abstract][Full Text] [Related]
7. Novel histone deacetylase inhibitors CG05 and CG06 effectively reactivate latently infected HIV-1.
Choi BS; Lee HS; Oh YT; Hyun YL; Ro S; Kim SS; Hong KJ
AIDS; 2010 Feb; 24(4):609-11. PubMed ID: 20154582
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of histone deacetylases: correlation between isoform specificity and reactivation of HIV type 1 (HIV-1) from latently infected cells.
Huber K; Doyon G; Plaks J; Fyne E; Mellors JW; Sluis-Cremer N
J Biol Chem; 2011 Jun; 286(25):22211-8. PubMed ID: 21531716
[TBL] [Abstract][Full Text] [Related]
9. NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation.
Williams SA; Chen LF; Kwon H; Ruiz-Jarabo CM; Verdin E; Greene WC
EMBO J; 2006 Jan; 25(1):139-49. PubMed ID: 16319923
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitor Scriptaid reactivates latent HIV-1 promoter by inducing histone modification in in vitro latency cell lines.
Ying H; Zhang Y; Lin S; Han Y; Zhu HZ
Int J Mol Med; 2010 Aug; 26(2):265-72. PubMed ID: 20596607
[TBL] [Abstract][Full Text] [Related]
11. Novel histone deacetylase inhibitor NCH-51 activates latent HIV-1 gene expression.
Victoriano AF; Imai K; Togami H; Ueno T; Asamitsu K; Suzuki T; Miyata N; Ochiai K; Okamoto T
FEBS Lett; 2011 Apr; 585(7):1103-11. PubMed ID: 21402072
[TBL] [Abstract][Full Text] [Related]
12. The novel histone deacetylase inhibitors metacept-1 and metacept-3 potently increase HIV-1 transcription in latently infected cells.
Shehu-Xhilaga M; Rhodes D; Wightman F; Liu HB; Solomon A; Saleh S; Dear AE; Cameron PU; Lewin SR
AIDS; 2009 Sep; 23(15):2047-50. PubMed ID: 19609198
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitor chidamide promotes reactivation of latent human immunodeficiency virus by introducing histone acetylation.
Kuai Q; Lu X; Qiao Z; Wang R; Wang Y; Ye S; He M; Wang Y; Zhang T; Wu H; Ren S; Yu Q
J Med Virol; 2018 Sep; 90(9):1478-1485. PubMed ID: 29704439
[TBL] [Abstract][Full Text] [Related]
14. Possible mechanism of action of the histone deacetylase inhibitors for the induction of differentiation of HL-60 clone 15 cells into eosinophils.
Ishihara K; Hong J; Zee O; Ohuchi K
Br J Pharmacol; 2004 Jul; 142(6):1020-30. PubMed ID: 15210580
[TBL] [Abstract][Full Text] [Related]
15. Histone deactylase inhibitor SAHA induces a synergistic HIV-1 reactivation by 12-O-tetradecanoylphorbol-13-acetate in latently infected cells.
Park SY; Kim KC; Hong KJ; Kim SS; Choi BS
Intervirology; 2013; 56(4):242-8. PubMed ID: 23735807
[TBL] [Abstract][Full Text] [Related]
16. HIV Provirus Stably Reproduces Parental Latent and Induced Transcription Phenotypes Regardless of the Chromosomal Integration Site.
Hashemi FB; Barreto K; Bernhard W; Hashemi P; Lomness A; Sadowski I
J Virol; 2016 Jun; 90(11):5302-14. PubMed ID: 26984732
[TBL] [Abstract][Full Text] [Related]
17. Synergistic reactivation of latent HIV-1 provirus by PKA activator dibutyryl-cAMP in combination with an HDAC inhibitor.
Lim H; Kim KC; Son J; Shin Y; Yoon CH; Kang C; Choi BS
Virus Res; 2017 Jan; 227():1-5. PubMed ID: 27677464
[TBL] [Abstract][Full Text] [Related]
18. In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection.
Tsai P; Wu G; Baker CE; Thayer WO; Spagnuolo RA; Sanchez R; Barrett S; Howell B; Margolis D; Hazuda DJ; Archin NM; Garcia JV
Retrovirology; 2016 May; 13(1):36. PubMed ID: 27206407
[TBL] [Abstract][Full Text] [Related]
19. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells.
Cheong JW; Chong SY; Kim JY; Eom JI; Jeung HK; Maeng HY; Lee ST; Min YH
Clin Cancer Res; 2003 Oct; 9(13):5018-27. PubMed ID: 14581377
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
Law AY; Lai KP; Lui WC; Wan HT; Wong CK
Exp Cell Res; 2008 Oct; 314(16):2975-84. PubMed ID: 18652825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]